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ABSTRACT 
Antibodies raised in rabbits to Triton-solubilized, purified acetylcholine receptor 
from Torpedo ca/ifornica were used to immunospecifically label intact T. californica 
electroplaque membrane vesicles attached to cover slips and oriented with the 
extracellular face of the synaptic membrane facing outward. Hemocyanin conju-
gated to Protein A was then used as a marker, making the antibody binding visible 
at the electron microscope level. Parallel labeling experiments were performed on 
vesicles attached to cover slips and sheared by sonication, leaving their cytoplasmic 
faces fully exposed to the labeling solution. While differences in antibody popu-
lations among different rabbits were observed, antigenic determinants of the 
receptor were present on both faces of the membrane, with those on the extracel-
lular side more numerous than those on the cytoplasmic side, demonstrating the 
transmembrane nature of the receptor molecule. 
KEY WORDS receptor . transmembrane · 
acetylcholine · antibodies · electron microscopy 
Membrane fragments containing up to 50% of 
their total protein as acetylcholine receptor 
(AcChR) 1 can be isolated from the electric organs 
of Torpedo californica (6, 8). Such membrane frag-
ments have most, if not all, of the molecular 
1 Abbreviations used in this paper: AcChR, acetylcholine 
receptor; a-BuTx, a-bungarotoxin; EAMG, experimental 
autoimmune myasthenia gravis; Hey I A, hemocyanin-
Protein A conjugate; Ig, immunoglobulin; MFTS, Tri-
ton-solubilized membrane fragment proteins; MFTS-R, 
Triton-solubilized membrane fragment proteins depleted 
in AcChR; NPE buffer, 10 mM Na-phosphate, 0.4 M 
NaCI, I mM EDTA, pH 7.4; NRG, pre-immune rabbit 
I g. 
properties of the postsynaptic membrane of the 
electroplaques; they bind a-neurotoxins (6, 8) and 
cholinergic ligands (27, 41) at structurally related 
sites and possess distinct binding sites for local 
anesthetics (7, 34, 41) and the alkaloid histrioni-
cotoxin ( 10, II). Cholinergic agonists binding to 
the AcChR cause the flux of inorganic cations 
through the membrane (4, 13, 17, 23), suggesting 
that the AcChR is all or part of a transmembrane 
complex. The question of the disposition of the 
AcChR molecule in the membrane, however, re-
mains a controversial issue. 
When examined at the electron microscope 
level, AcChR-enriched membrane fragments are 
observed to be mostly in the form of vesicles, with 
densely packed cylindrical rosettes 60-80 A in 
diameter (3, 24, 28) that become more prevalent 
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as the membrane preparations become more en-
riched in AcChR. Negative staining of Triton-
solubilized purified AcChR reveals these same 
rosettes (3, 9, 32, 38). This correlation of the 
presence of the rosettes and that of the AcChR, as 
well as the recent immunospecific labeling of neg-
atively stained membrane fragments with antibod-
ies to AcChR by Klymkowsky and Stroud (18), 
has led to the identification of this rosette structure 
as the AcChR molecule. X-ray diffraction studies 
of AcChR-enriched T. californica membrane frag-
ments by Ross et al. (32) have shown that the 
protein present spanned the membrane, extending 
55 A on one side of the bilayer and 15 A on the 
other. Likewise, Rash et al. (30) observed trans-
membrane staining with Os04/K3Fe(CN)s of the 
protein at mammalian neuromuscular junctions 
and in membrane preparations from Torpedo os-
cellata and correlated this with anti-AcChR anti-
body binding they observed on one side of these 
same membranes. In studies of visualization of the 
binding of ferritin-conjugated anti-AcChR anti-
bodies to Torpedo membrane vesicles by electron 
microscopy of thin sections, Karlin et al. (15) 
found antibody binding to the outside surface of 
the vesicles with some labeling on the inside sur-
face which they were unable to distinguish from 
nonspecific trapping that occurred. Using the same 
experimental approach, Tarrab-Hazdai et al. (40) 
observed some binding of anti-AcChR antibodies 
to both sides of the membrane of some open 
vesicles as evidence that the receptor spans the 
membrane. 
A major problem in these studies has been in 
ascertaining the accessibility of both sides of the 
membrane to the antibody molecules. The recent 
isolation of intact, outside-out receptor-containing 
membrane vesicles provides a method for deter-
mining which side of the electroplaque synaptic 
membrane (cytoplasmic or extracellular) corre-
sponds to which side of the isolated membrane 
vesicles being labeled in such studies (12). We 
report here the use of such intact vesicles with 
their extracellular faces exposed for immunospe-
cific labeling of the AcChR molecule. In further 
studies the vesicles were sheared, exposing their 
cytoplasmic faces to the immunospecific labeling 
reagents and providing a well-defmed preparation 
for determining the transmembrane nature of the 
AcChR. 
MATERIALS AND METHODS 
Crude membrane fragments were prepared from T. californica 
electroplax by the method of Reed et a!. (31 ). Purified AcChR. 
solubilized in Triton, was prepared from crude membrane frag-
ments according to Schmidt and Raftery using affinity chroma-
tography (35). Intact, right-side out vesicles enriched in AcChR 
(0.5-1.5 nmol a-bungarotoxin (a-BuTx) sites per mg of total 
protein) were made in 10 mM Na-phosphate, 0.4 M NaCI, I mM 
EDTA, pH 7.4 (NPE buffer) (12). Briefly, crude membrane 
fragments were prepared in isotonic buffer and were then frac-
tionated on a 4-20% sucrose gradient at 195,700 g for I h. The 
osmotically intact AcChR-enriched vesicles banded at the top of 
the gradient. The sidedness of the vesicles was determined by the 
a-BuTx sites assay described by Hartig and Raftery ( 12). Intact 
vesicles were first incubated with an excess of 1"I-a-BuTx "pre-
pared by the method of Clark et a!. ( 4) and Blanchard et a!. (I), 
in NPE. After 30 min, identical aliquots were diluted into (a) 10 
mM Na-phosphate, 50 mM NaCI, 0.1% Triton (wash buffer) 
(total sites sample) and (b) wash buffer containing an excess of 
unlabeled a-BuTx (outside sites sample). After 30-min further 
incubation, 0.1-ml aliquots were applied to Whatman DE-81 
discs and washed for 30 min in wash buffer, with three changes, 
before counting in a Beckman Gamma-4000 gamma counter 
(Beckman Instruments, Inc., Fullerton, Calif.). The fraction of 
outside-out (extracellular side out) vesicles was determined from 
the ratio (outside sites counts]!(total sites counts]. 
a-BuTx was purified from the venom of Bungarus multicinctus 
by the method of Clark et a!. (4). Triton-solubilized membrane 
fragment proteins depleted in AcChR (MFTS-R) were prepared 
by removing the AcChR from Triton-solubilized membrane 
fragments on an a-BuTx affinity column, and were the gift ofT. 
Claudio. 
Protein concentrations were determined by the method of 
Lowry et a!. (22) using bovine serum albumin as the standard. 
The concentration of a-BuTx sites was determined according to 
Schmidt and Raftery (36) using DEAE-cellulose filter discs and 
125I-a-BuTx. SDS polyacrylamide gel electrophoresis was done 
according to Laemmli (20), with a 12.5% acrylamide, 0.1% meth-
ylene-bis-acrylamide separating gel and a 3% acrylamide, 0.08% 
bis-acrylamide stacking gel. Immunodiffusion assays were con-
ducted according to Ouchterlony (25). 
Preparation of Antibodies 
Antibodies to Triton-solubilized, purified AcChR (anti-
AcChR) from T. californica were raised in New Zealand white 
rabbits according to Claudio and Raftery (5). The purity of the 
AcChR was checked on SDS gels before injection, with pure 
AcChR defined as the complex consisting of only the four 
polypeptide chains previously described (16, 29). Over a period 
of 2 yr, six different rabbits were injected with several different 
AcChR preparations (see Table I); only two of the rabbits (Nos. 
5 and 6) received the same AcChR preparation. 0.5-1 mg of 
AcChR emulsified in Freund's complete adjuvant was injected 
subcutaneously at multiple sites along the back. 1-2 wk after 
boosting, all but one of the rabbits displayed the paralysis symp-
tomatic of experimental autoimmune myasthenia gravis 
(EAMG) (26) and were bled to death. Rabbit No. 2. despite 
repeated injections, never showed symptoms of the disease; 40 
ml of blood was obtained from an ear vein weekly for 2 wk afte1 
each challenge of this rabbit. Antibodies to a-BuTx were pre-
pared following the same injection schedule, using 0.1 mg a-
BuTx emulsified in Freund's complete adjuvant per injection. 
The immunoglobulin fraction of antisera (Ig) was prepared by 
two fractionations with ammonium sulfate (0-33%), and the 
pellets were dialyzed against phosphate-buffered saline (PBS). 
This immunoglobulin fraction was clarified by centrifugation at 
15,000 g for 30 min before dilution into NPE for the labeling 
experiments. Normal rabbit Ig (NRG) was prepared by ammo-
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nium sulfate fractionation of pre-immune serum. Antibody titers 
were determined by the method of Claudio and Raftery (manu-
script in preparation). Triton-solubilized, purified AcChR, bound 
to 125I-a-BuTx, was incubated with the Ig fraction of the anti-
AcChR serum at room temperature. After l h, enough Staphy-
lococcus aureus to precipitate all the IgG was added and incu-
bated for 30 min. The solution was centrifuged at 15,000 g for 5 
min, and the pellet was washed in lO mM Na-phosphate, 0.1% 
Triton, and counted on a Beckman Gamma-4000 gamma 
counter. 
Hemocyanin-Protein A conjugate (Hey/A) was prepared by 
the method of Miller et a!. (manuscript in preparation), using 
glutaraldehyde as the cross-linking reagent. l ml of hemocyanin 
(70 mg/ml), purified by centrifugation and gel filtration from the 
hemolymph of Busycon cana/iculatum, and l ml of Protein A 
(Pharmacia Inc., Piscataway, N. J.; 3.6 mg/ml) were conjugated 
with 0.22 ml of 0.5% glutaraldehyde. After 45 min at room 
temperature, 0.2 ml of 2 M glycine was added to bind unreacted 
glutaraldehyde. After 15 min at room temperature, the solution 
was dialyzed for 24 h at 4°C against PBS, and the Hey/A 
conjugate was separated from unconjugated Protein A by passage 
over a Sepharose 2B column. 
Labeling of Intact and Broken Vesicles 
with Antibodies 
INTACT VESICLE LABELING: To attach intact vesicles to 
cover slips, the glass cover slips were first treated with l% Alcian 
Blue (39) for 15 min and washed three times in NPE. 50111 of 
intact vesicles (2 mg/ml) were incubated on the cover slip for 15 
min, and the excess membranes were rinsed off with NPE. For 
identification of AcChR antigenic determinants, 35 111 of anti-
AcChR Ig from each of the six rabbits (0.5 mg/ml) were then 
incubated on the cover slip for 30 min at room temperature. The 
cover slip was then rinsed three times in NPE, and treated with 
Hey I A as described below. BuTx-binding sites were visualized 
by incubation of the cover slip in a-BuTx (0.02 mg/ml) for 45 
min before treatment with anti-BuTx Ig and Hey/A. Control 
experiments were done by substituting NRG for immune anti-
bodies. 
CYTOPLASMIC MEMBRANE LABELING: To expose the cy-
toplasmic face of the vesicles, a modification of the method of 
Jacobson and Branton (14) was used. The cover slip was clamped 
between two pieces of plexiglass with a hole exposing most of the 
surface of the cover slip. This apparatus was suspended in l liter 
of cold NPE and sonicated in a bath sonicator (Laboratory 
Supplies Co., Inc., Hicksville, N. Y.) at 80kHz for 5 min. The 
cover slip was then removed and labeled with antibodies as 
described above. 
HCY /A LABELING OF IMMUNOLABELED VESICLES: 
After labeling with immune or pre-immune antibodies, the cover 
slips containing intact or sonicated vesicles were incubated with 
Hey 1 A ( 1.5 mg/ml in NPE) for 30 min at room temperature and 
washed three times in NPE. 
Preparation of Samples for 
Electron Microscopy 
Immediately after labeling with Hey I A, samples were fixed 
in l% glutaraldehyde in NPE for several hours, followed by 
fixation in 1% Os04 in half-strength NPE for l hat 4°C. After 
dehydration in a graded series of ethanol solutions, the samples 
were dried at the critical point using co, as the transition fluid 
in a Polaron apparatus (Polaron Instruments Inc., Line Lexing-
ton, Pa. ). The cover slips were shadowed at a 45 ° angle with 
platinum/palladium followed by coating with carbon at a 90° 
angle in a vacuum evaporator. Replicas were then separated 
from the glass cover slip by etching with 48% hydrofluoric acid, 
and the membrane fragments were removed with twice-filtered 
household bleach. After rinsing with water, the replicas were 
deposited on copper grids and examined in a Philips 201 electron 
microscope. 
RESULTS 
The intact vesicles described here were from 94 to 
100% extracellular side-out, i.e., 94-100% of the 
total a-BuTx sites were exposed on the outside 
surface of the vesicles, as determined by the a-
BuTx binding assay described in Materials and 
Methods. When examined at the electron micro-
scope level, replicas ofthese preparations consisted 
of spherical vesicles ranging in diameter from O.l 
to I }Lm (see Fig. I a). Upon sonication for 5 min, 
the vesicles appeared as flat circles with a rough 
texture, often with a thickening at the perimeter 
attributable to edges not attached to the Alcian-
blue coating (Fig. I e). A time-course of the effects 
TABLE I 
Characterization ofAnti-AcChR Antisera 
Titers• Ouchterlony reactions* EM studies with Hey I A 
Contracted nmol o:-BuTx Extracellular Cytoplasmic 
Rabbit No. EAMG sites pmol AcChR AcChR MFTS MFTS-R labeling labeling 
yes 0.32 2.00 ++++ ++++ yes no 
2 no 0.51 3.00 ++++ ++++ ++ yes no 
3 yes 0.65 4.06 ++++ ++++ yes no 
4 yes 0.54 3.37 ++++ ++++ + yes no 
5§ yes 1.95 12.17 ++++ ++++ yes yes 
6§ yes 2.35 14.16 ++++ ++++ yes no 
* Titers are given per milliliter of serum. 
t Ouchterlony results are as judged visually, with++++ indicating a very strong reaction, +a very weak reaction, 
and - no reaction. 
§ These two rabbits were i!ljected with the same preparation of AcChR. 
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of sonication showed that after 2 min most vesicles 
maintained intact their spherical shape, while by 
5 min -95% of the vesicles had been sheared, 
leaving their inside faces exposed. At times longer 
than lO min vesicles were frequently totally re-
moved from the Alcian blue, and after 30 min the 
Alcian blue began to pucker and detach. Occa-
sionally, vesicles could be found which had col-
lapsed during sonication and were not sheared off. 
Such collapsed vesicles could be readily distin-
guished from sheared vesicles in both labeled and 
unlabeled preparations by the smoother and more 
three-dimensional appearance of the former (see 
Fig. I). 
The binding of anti-AcChR and anti-BuTx Ig 
to intact and sheared vesicles is summarized in 
Tables II and III. That the intact vesicles were 
oriented mainly so that their extracellular, a-
BuTx-binding side faced outward was verified at 
the electron microscope level by the binding of 
a-BuTx and anti-BuTx Ig, visualized with the 
Hey I A marker. As can be seen in Fig. 2 a, the 
outsides of several vesicles treated with a-BuTx 
and anti-BuTx Ig, visualized with Hey/A, were 
coated with the Hey I A markers. Upon sonication, 
the inside surfaces of the vesicles were exposed but 
no a-BuTx binding could be discerned (Fig. 2b). 
Control experiments in which vesicles were treated 
with NRG and Hey/A showed no labeling on 
either the intact or the sonicated vesicles (Fig. 3). 
With all six anti-AcChR Ig preparations, the ex-
tracellular faces of the membranes were labeled 
(Fig. 4a). With both anti-BuTx and anti-AcChR 
Ig's, a high proportion (70-80%) of the larger 
intact vesicles ( -0.5 ~-tm in diameter and larger) 
were heavily labeled, while most of the smaller 
vesicles and some of the larger ones were not 
labeled at all with either antibody. 
When the sonicated vesicles were treated with 
anti-AcChR Ig, there was a dramatic difference in 
labeling from one antibody preparation to the 
next. With anti-AcChR Ig's from rabbits Nos. l, 
2, 3, 4, and 6, there was little if any labeling on the 
insides of the vesicles (Fig. 4 b). Occasionally, 
inside labeling of the vesicles was observed (Fig. 
4c), but it was usually sparse and could be corre-
lated with an increase in the background labeling 
of the Alcian blue, suggesting that insufficient 
washing may have caused nonspecific disposition 
of Hey I A on the vesicle surface. In other cases 
(Fig. 4d), label was observed only around free 
edges of the vesicle which had curled over and 
faced upward, exposing a narrow rim of external 
AcChR sites to the anti-AcChR Ig solution. 
With anti-AcChR Ig from rabbit No. 5, soni-
cated vesicles were heavily labeled (Fig. 4e). The 
density of Hey I A markers on the vesicles was up 
to 15 times higher than that on the Alcian-blue 
background, an increase comparable to that ob-
served in the labeling of intact vesicles with anti-
AcChR Ig (compare Fig. 4a and e). As in the 
labeling of intact vesicles, it was mainly the larger 
sonicated vesicles that were labeled with anti-
AcChR Ig from rabbit No. 5; most of the smaller 
vesicles and some of the larger ones did not label 
at all (Fig. 4/). 
The labeling results are summarized in Tables 
II and III. All vesicles in large fields (each con-
taining -200 vesicles) of intact or sheared vesicles 
treated with each of the anti-AcChR preparations, 
a-BuTx + anti-BuTx, or NRG were examined and 
the percentage of vesicles labeled with Hey I A 
FIGURE I (a) Two intact Torpedo electroplaque membrane vesicles, with the extracellular side (E) of the 
synaptic membrane exposed. The vesicles are smooth and spherical. X 60,000. (b) An intact vesicle, 
extracellular side (E) exposed, labeled with anti-AcChR and Hey/ A. The spherical shape of the vesicle 
can be distinguished beneath the hemocyanin markers (h). X 50,000. (c) A deflated membrane vesicle (D), 
with its extracellular side exposed, appears as a smooth but flat circle. X 43,000. (d) A deflated vesicle (D), 
labeled with anti-AcChR and Hey I A. The smooth surface of the vesicle can be seen beneath the 
hemocyanin markers (h). (e) Membrane vesicles after 5-min sonication. The vesicles have been sheared, 
leaving the rough cytoplasmic face (C) of the membrane exposed. A thickening around the rim of the 
vesicle (r) can be attributed to membrane not attached to the Alcian blue. These vesicles can be readily 
distinguished from deflated vesicles (Fig. I c) by the roughness of the cytoplasmic face. X 68,000. (j) A 
sheared membrane vesicle after 5-min sonication, labeled with anti-AcChR from rabbit No. 5 and Hey/ 
A. The rough, cytoplasmic face of the membrane (C) can be identified beneath the hemocyanin markers 
(h). These sheared, labeled vesicles can be easily distinguished from intact, labeled vesicles and deflated, 
labeled vesicles, as can be seen by a comparison of b, d, and f X 50,000. 
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TABLE II 
Antibody Labeling of Vesicles in a Single Field, According to Size 
Vesicle diameter ;,:5,000 A 3,000-5,000 A 1,000-3,000 A ,;1,000 A 
No.la-
Vesicle prep- beled/to- %La- No.la- %La- No.la- %La- No.la- %La-
Antibody preparation aration tal be led beled/total be led beled/total be led beled/total be led 
Anti-AcChR No. I Intact 5/7 71 11/36 31 3/152 2 0/72 0 
sheared 0/3 0 l/6 17 0/30 0 0/22 0 
Anti-AcChR No. 2 Intact 7/13 54 14/40 35 3/106 3 0/66 0 
sheared 0/3 0 0/10 0 0/51 0 0/120 0 
Anti-AcChR No.3 Intact 7/8 88 10/42 24 6/147 4 0/73 0 
sheared 0/2 0 0/10 0 0/22 0 0/92 0 
Anti-AcChR No. 4 Intact 8/11 73 9/31 29 6/116 3 0/89 0 
sheared 0/4 0 l/12 8 !/II 9 0/43 0 
Anti-AcChR No. 5 Intact 5/7 71 7/24 29 6/163 2 0/70 0 
sheared 5/6 83 10/38 26 3/45 7 0/78 0 
Anti-AcChR No.6 Intact 4/5 80 10/40 25 5/152 3 0/87 0 
sheared 0/3 0 1/34 3 3/47 6 0/49 0 
Anti-BuTx Intact 4/5 80 8/36 22 2/108 2 0/95 0 
sheared 0/2 0 0/21 0 0/26 0 0/92 0 
NRG Intact 0/10 0 0/52 0 0/104 0 0/83 0 
sheared 0/8 0 0/12 0 0/27 0 0/17 0 
TABLE II, SUMMARY 
(A) Extracellular surface labeling(% labeled) (B) Cytoplasmic surface labeling(% labeled) 
Vesicle 
diameter 
3,000- 1,000- ,;1,000 3,000- 1.000- ,;1,000 
Antibody ;,:5000 A 5,000 A 3.000 A A Antibody ;,:S,OOOA s,ooo A 3.000 A A 
Anti-AcChR 73 ± 9 29 ± 4 3 ± 0.8 0 Anti-AcChR 0 6±7 3±4 0 
No. 1-6 Nos. 1-4,6 
Anti-BuTx 80 ± 10 22 ± 3 2 ± 0.5 0 Anti-AcChR 83 ± 10 26 ±4 7±7 0 
No.5 
NRG 0 0 0 0 Anti-BuTx 0 0 0 0 
NRG 0 0 0 0 
All vesicles in a single field were counted for each antibody category and the percentage of labeled vesicles for each 
size range determined. The results are summarized in the lower half of the table. 
TABLE III 
Antibody Labeling of Intact and Sheared Vesicles 
Vesicle diameter ;,:5,000 A 3,000-5,000 A 
Antibody No. labeled/total %Labeled No. labeled/total %Labeled 
(A) Extracellular surface labeling 
Anti-AcChR Nos. 1-6 56/73 77 ± 9 54/189 29 ± 4 
Anti-BuTx 35/49 71 ± 9 11/49 22 ± 3 
NRG 0/52 0 0/52 0 
(B) Cytoplasmic surface labeling 
Anti-AcChR Nos. l-4,6 2/58 3 ± 3 3/78 4±3 
Anti-AcChr No. 5 39/50 78 ± 10 13/51 25 ± 3 
Anti-BuTx 2/52 4±3 1/57 2±2 
NRG 0/51 0 0/42 0 
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FIGURE 2 Vesicles treated with a-BuTx followed by anti-BuTx and Hey/ A. (a) Hemocyanin molecules 
(h) can be seen as round or square particles on the external surface (E) of the larger intact vesicles. The 
small vesicles are not labeled and are probably lipid vesicles. A deflated vesicle (D) can be identified by 
its distinctive shape and smoothness. X 31,000. (b) After sonication, the vesicles are sheared, exposing 
their cytoplasmic sides (C). Hemocyanin molecules (h) appear in the background, but only one can be 
detected at the edge of a vesicle. X 49,500. 
FIGURE 3 Control experiment in which vesicles were treated with pre-immune rabbit Ig and Hey/ A. (a) 
With intact vesicles there was no labeling of the extracellular side of the membrane (E). X 50,000. (b) 
After sonication, the cytoplasmic side of the membrane (C) was exposed and did not label. X 81,000. 
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markers for each of four size ranges (diameters of 
~5,000; 3,000-5,000; 1,000-3,000; and ::;1,000 A) 
was determined. As is clear from Table II, the 
AcChR-containing vesicles are essentially all 
larger than 3,000 A in diameter, with 70-80% of 
the intact vesicles larger than 5,000 A and 20-30% 
of those in the 3,000-5,000 A range containing 
AcChR, as determined by Hey I A visualization of 
both anti-AcChR and a-BuTx + anti-BuTx bind-
ing. To provide a better statistical sample from 
which to determine whether anti-AcChR from 
rabbit No. 5 did indeed consistently label the 
insides of AcChR-containing vesicles, 40 or more 
vesicles with diameters of 3,000-5,000 A and 40 or 
more with diameters ~ 5,000 A were examined for 
Hey I A labeling after treatment with anti-AcChR, 
a-BuTx + anti-BuTx, or pre-immune Ig. Anti-
AcChR from rabbits Nos. 1-4 and 6 and anti-
BuTx behaved the same way, again labeling 70-
80% of the largest vesicles and 20-30% of the 
3,000- to 5,000-A vesicles on the extracellular side 
of the membrane and essentially none on the 
cytoplasmic side. This larger sampling also con-
firmed the result indicated in the smaller sampling 
in Table II: anti-AcChR from rabbit No. 5 labeled 
the cytoplasmic side of the membranes on 78% of 
the ~5,000-A vesicles and 25% of the 3,000- to 
5,000-A vesicles, the same amount of labeling 
observed on the extracellular sides of these vesicles 
with a-BuTx + anti-BuTx and with all six anti-
AcChR preparations (including that from rabbit 
No. 5). Pre-immune Ig labeled on neither the 
insides nor the outsides of vesicles in any size 
range. 
Ouchterlony immunodiffusion assays of each 
anti-AcChR Ig preparation against purified 
AcChR, Triton-solubilized membrane fragments 
(MFTS), and MFTS-R showed a strong reaction 
of all anti-AcChR Ig against AcChR and against 
MFTS (see Fig. 5). Only one preparation (from 
rabbit No. 2) reacted moderately with the MFTS-
R (see Table 1). With one other anti-AcChR Ig 
preparation, a barely discernible reaction was re-
corded. With the other four anti-AcChR Ig prep-
arations (including that from rabbit No. 5), no 
reaction with the MFTS-R was observed. 
DISCUSSION 
The experimental evidence presented here indi-
cates that the AcChR, composed of four subunits 
with mol wt of 40,000, 50,000, 60,000, and 65,000 
(16, 28, 29), is a transmembrane protein. The 
method of immunospecific labeling used permits 
complete exposure of both the extracellular and 
the cytoplasmic faces of the membrane to the 
antibody solution. These faces could be clearly 
identified as the extracellular face of the synapse 
corresponding to the outside face of the membrane 
vesicle and the cytoplasmic face to the inside of 
the vesicle by Hey I A visualization of the binding 
of a-BuTx and anti-BuTx. Hemocyanin has 
proven to be a highly visible marker in TEM 
studies of smooth cellular or membrane surfaces 
(2, 37), and the specificity of Hey I A for IgG, 
already established by Miller et al. (manuscript in 
preparation), is here shown again by the lack of 
labeling with NRG. The use of osmotically intact 
vesicles permitted the use of a 1251-a-BuTx binding 
assay to confirm that most of the vesicles were 
indeed "right-side out," i.e., most of the a-BuTx 
sites were exposed on the outside surface of the 
vesicles, in agreement with the observations of 
Hartig and Raftery ( 12). 
In the labeling of intact vesicles with anti-
AcChR Ig, the results obtained with antisera from 
different rabbits were in excellent agreement. An-
FIGURE 4 Vesicles treated with anti-AcChR followed by Hey/A. (a) Intact vesicles treated with any of 
the six anti-AcChR preparations were labeled with hemocyanin (h) on their external surfaces. As in Fig. 
2, most of the larger vesicles were labeled, while the smaller ones were not. X 31,000. (b-d) Vesicles after 
sonication, treated with anti-AcChR from rabbit No. I, 2, 3, 4, or 6. (b) Few hemocyanin molecules (h) 
can be seen on the cytoplasmic side of the membrane or on the background. x 3 7 ,000. (c) An increase in 
the hemocyanin (h) labeling of the cytoplasmic membranes corresponds to an increase in the hemocyanin 
in the background. X 43,000. (d) The cytoplasmic face (C) of the sheared vesicle can be seen with 
thickening around the free edges (r). The entire rim is labeled with hemocyanin molecules (h), with none 
in the center. X 66,000. (e and f) Vesicles after sonication, treated with anti-AcChR from rabbit No.5. (e) 
A close-up of one vesicle shows the characteristic rough cytoplasmic side of the membrane heavily labeled 
with hemocyanin (h). X 47,000. (j) A view of a larger field shows sheared vesicles with their cytoplasmic 
sides exposed. (L) A large vesicle is labeled with hemocyanin (h), while several smaller vesicles are 
unlabeled ( U). X 22,000. 
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FIGURE 5 Ouchterlony immunodiffusion assays. The 
numbers 1-6 indicate the wells which were filled with 
anti-AcChR Ig from rabbits 1-6. The antigens in the 
center wells were (a) AcChR, (b) MFTS, and (c) MFTS-
R. The arrow points out the faint cross-reaction observed 
between MFTS-R and Ig from rabbit No.2. 
tisera from all rabbits showed equal labeling of 
the outside (extracellular) faces of intact vesicles. 
The observation that the same proportion of vesi-
cles of each size range was labeled with both anti-
BuTx and anti-AcChR Ig is indicative of the 
specificity of the antibodies for the AcChR since 
it indicates that the same vesicles were labeled 
with both reagents. The differences in labeling 
from one antibody preparation to the next became 
apparent only in the labeling of the cytoplasmic 
faces of sonicated vesicles, where anti-BuTx and 
five of the six preparations of anti-AcChR showed 
little or no labeling and one showed labeling com-
parable to that seen on the extracellular face of the 
membranes. 
That the labeling seen with anti-AcChR from 
rabbit No. 5 was specific labeling of the AcChR 
on the cytoplasmic face of the membrane was the 
conclusion drawn from several lines of evidence. 
(a) The AcChR injected into the rabbit producing 
these antibodies was highly purified as judged by 
its SDS gel electrophoresis profile, having a gel 
pattern consistent with that of pure T. ca/ifornica 
AcChR (16, 28, 29). Furthermore, the same 
AcChR preparation was injected at the same time 
into another rabbit (No. 6) whose antisera were 
also used in these studies. The antibodies from 
rabbit No. 6 did not react with the cytoplasmic 
sides of the vesicles, ruling out the possibility that 
there was simply a variation in the AcChR prep-
aration used to immunize the rabbit which caused 
this labeling of the cytoplasmic face. (b) The im-
munodiffusion results indicate that it is in all 
likelihood not a contaminant in the AcChR in-
jected into the rabbit that causes labeling of the 
cytoplasmic face with the antibodies from rabbit 
No. 5. In the interaction between the various anti-
AcChR Ig preparations and MFTS-R, there was 
no discernible reaction with immunoglobulins 
from rabbit No. 5. There was, however, a very 
faint reaction with the antisera from rabbit No. 2 
and a barely discernible reaction with antisera 
from rabbit No. 4, neither of which labeled the 
cytoplasmic face. (c) All labeling experiments were 
repeated three times with three different intact 
vesicle preparations, yielding the same results. 
Therefore, the labeling of the cytoplasmic face of 
the membrane by this anti-AcChR preparation 
was a real phenomenon and not an artifact caused 
by insufficient washing of one sample. (d) Finally, 
the statistics of labeling given in Tables II and III 
indicate that the AcChR-containing vesicles can 
be identified by their large size. It is these large 
vesicles that label with both anti-AcChR (77%) 
and anti-BuTx (71%) on the extracellular face and 
which also label with this anti-AcChR preparation 
(78%) on the cytoplasmic face. This statistical 
agreement also holds for vesicles in the 3,000- to 
5,000-A range, 20-30% of which contain AcChR. 
That none of the vesicles labeled with pre-immune 
Ig on either side nor with a-BuTx + anti-BuTx on 
the cytoplasmic side also indicates that the labeling 
observed is specific for the given antibody-antigen 
interaction. 
It is not unusual that different rabbits injected 
with the same antigen would produce antibodies 
of differing specificities; these experimental rabbits 
are outbred population and their immune re-
sponses are not homogeneous. Such differences in 
the specificities of rabbit antibodies have been 
found in studies of the functional effects of anti-
AcChR antibodies (15, 33) and of anti-Na'\K+-
ATPase antibodies (19). That only one out of six 
rabbits displayed an immune response to antigens 
on the inside face of the membrane indicates either 
that the portion of the receptor exposed on this 
side is not very antigenic and/ or that only a small 
portion of the molecule is exposed on the cyto-
plasmic face. This concurs with the findings of 
Ross et al. (32), who determined that protein 
protruded only 15 ± 5 A on one side of the 
membrane of AcChR-enriched preparations while 
extending 55 ± 5 A from the other side. 
In thin-section electron micrographs of the la-
beling of membrane-fragments in solution with 
ferritin-conjugated anti-AcChR antibodies, Tar-
rab-Hazdai et al. (40) saw some labeling of both 
sides of open vesicles, while Karlin et al. (15) saw 
some inside labeling, but were unable to distin-
guish it from nonspecific sticking of ferritin. This 
difference may also have resulted from differing 
specificities of the anti-AcChR antibody prepara-
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tions used. In the labeling of whole vesicles with 
antibody molecules, the insides are often not ac-
cessible to the labeling reagents (40; C. D. Strader, 
unpublished observations) and there can be non-
specific trapping of labels inside the vesicles. Pre-
liminary observations both by electron microscopy 
(C. D. Strader, unpublished observations) and by 
flux measurements (H.-P. Moore and P. Hartig, 
unpublished observations) indicate that Torpedo 
membrane vesicles reseal after osmotic shock, thus 
complicating this experimental approach. The la-
beling method described here avoids any ambi-
guities caused by inaccessibility or by trapping of 
label inside the vesicles, since only the extracellu-
lar side or only the cytopasmic side of the mem-
brane is completely exposed to the labeling solu-
tion. 
The AcChR consists of four subunits of mol wt 
40,000, 50,000, 60,000, and 65,000 daltons (16, 28, 
29). By lactoperoxidase-catalyzed iodination of the 
outsides of intact vesicles, Hartig and Raftery 
(manuscript in preparation) have shown that por-
tions of all four ofthe AcChR subunits are exposed 
on the extracellular face of the synaptic mem-
brane. Lindstrom et al. (21) have shown that an-
tibodies to each of the AcChR subunits cross-react 
with rat muscle receptors in vivo, causing a de-
crease in muscle AcChR content. Hence, each of 
these four polypeptide chains must contain at least 
some antigenic determinants exposed on the extra-
cellular face of the membrane. 
Attempts to label the membrane vesicles with 
antibodies to individual AcChR subunits have 
been unsuccessful. This is probably due to the 
failure of such antibodies (prepared against the 
denatured individual subunits isolated from pre-
parative SDS polyacrylamide gels) to react with 
native, membrane-bound AcChR as observed with 
electron microscopy. Therefore, it was not possible 
to determine by this method which of the subunits 
are exposed on the extracellular side and which on 
the cytoplasmic side of the membrane. 
In conclusion, we have developed an unambig-
uous method for irnmunospecific labeling of the 
extracellular face or of the cytoplasmic face of 
membrane vesicles enriched in AcChR. The 
AcChR is a complex molecule consisting of four 
polypeptide subunits which remain together as a 
complex in the presence of Triton (35) and cholate 
(Elliott et al., manuscript in preparation) and 
which dissociate only when denatured in SDS 
(29). Antibodies to the AcChR containing only 
these four subunits were prepared and used to 
label a preparation of vesicles (12) in which 94-
100% of the a-BuTx-binding sites were on the 
outside surface of the membrane. Thus, in these 
vesicles, almost all of the AcChR molecules were 
at least partially exposed to the outside surface of 
the vesicles (corresponding to the extracellular face 
of the postsynaptic membrane). All preparations 
of anti-AcChR antibodies were found to bind to 
the outer surface of the vesicles, and one prepa-
ration also bound to the inner surface of the 
vesicles. Therefore, one or more of the four poly-
peptide subunits of the AcChR used as the antigen 
for production of these antibodies is exposed on 
the extracellular face of the membrane, and one 
or more is exposed on the cytoplasmic face of the 
membrane. Thus, it may be concluded from this 
evidence that the AcChR is a transmembrane 
protein, with many antigenic determinants on the 
extracellular face of the synaptic membrane and 
with few of the antigenic determinants protruding 
on the cytoplasmic face of the membrane. 
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